Anti-TNFRSF4 Mouse Monoclonal Antibody [Clone ID: OTI2F12A2] M02495-2 from BosterBio | Biocompare.com

Be the first to write a review!

Supplier Page from
BosterBio for
Anti-TNFRSF4 Mouse Monoclonal Antibody [Clone ID: OTI2F12A2]

BosterBio's Anti-TNFRSF4 Mouse Monoclonal Antibody [Clone ID: OTI2F12A2] is a Mouse monoclonal antibody. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Flow Cytometry, and Western Blot.

Description

Boster Bio TNFRSF4 mouse monoclonal antibody,clone OTI2F12A2. Catalog# M02495-2. Tested in FC, WB. This antibody reacts with Human

Product Specs
ItemAnti-TNFRSF4 Mouse Monoclonal Antibody [Clone ID: OTI2F12A2]
CompanyBosterBio
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberM02495-2
ClonalityMonoclonal
StorageStore at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles
ReactivityHuman
FormatPBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide
IsotypeIgG1
ApplicationsFlow Cytometry,WB
ImmunogenFull length human recombinant protein of human TNFRSF4 (NP_003318) produced in HEK293T cell
HostMouse
Quantity100 µl
PurityPurified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
NCBI Full Gene NameTNF receptor superfamily member 4
NCBI Gene AliasesACT35, CD134, IMD16, OX40, TXGP1L

Add to Compare List

BosterBio

BosterBio

3942 B Valley Ave.

Pleasanton, CA 94566

United States

Phone: (888) 466-3604
Fax: (925)215-2184

Email: support@bosterbio.com

Company Profile

Website: www.bosterbio.com

Be the First to Write a Review!

Webinar: Improving Cancer Biomarker Detection with Multiplex Technology
The quantification of soluble biomarkers, including chemokines and cytokines, in plasma or serum is ... Read More
Screening of Leukemic Neoantigen Specific T cells with the iQue Screener PLUS
In this webinar, Alison Tarke, a Research Scientist at PersImmune, delivers the presentation "... Read More